Filing Flows › Insulet (PODD) › Operating margin
Insulet (PODD) operating margin by quarter
Insulet's operating margin was 22.5% in Q3 2026 (third quarter 2026), +6.4 pts from Q2 2026. Over the last 7 quarters it ranged from 15.6% (Q1 2025) to 22.5% (Q3 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 22.5% | +6.4 pts | +5.9 pts |
| Q2 2026 | 16.2% | +0.1 pts | -2.5 pts |
| Q1 2026 | 16.0% | -2.6 pts | +0.4 pts |
| Q4 2025 | 18.7% | +2.0 pts | — |
| Q3 2025 | 16.7% | -2.0 pts | — |
| Q2 2025 | 18.7% | +3.1 pts | — |
| Q1 2025 | 15.6% | — | — |
Q3 2026 at a glance
Insulet, Q3 2026: revenue $842M (+19% year over year), operating margin 22.5%, net earnings $141M, operating cash flow $124M. The chart follows the revenue to costs, profit and cash.
Questions
What is Insulet's operating margin?
Insulet's operating margin was 22.5% in Q3 2026 (third quarter 2026), +6.4 pts from Q2 2026.
How has Insulet's operating margin changed?
Over the last 7 quarters it ranged from 15.6% (Q1 2025) to 22.5% (Q3 2026).